Intervention With a GABA Supplement in Prediabetics

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
In this double-blind parallel placebo controlled intervention study the effects of 3 times daily 500 mg gamma-aminobutyric acid (GABA) supplementation on glucose tolerance and cardiovascular health will be assessed in prediabetics.
Epistemonikos ID: 220b477582396f47659152f25928fca4c2621e3e
First added on: May 07, 2024